A detailed history of Yousif Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 23,146 shares of BIIB stock, worth $4.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,146
Previous 23,264 0.51%
Holding current value
$4.02 Million
Previous $5.39 Million 16.82%
% of portfolio
0.05%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$189.07 - $236.8 $22,310 - $27,942
-118 Reduced 0.51%
23,146 $4.49 Million
Q2 2024

Jul 31, 2024

SELL
$190.52 - $236.72 $174,325 - $216,598
-915 Reduced 3.78%
23,264 $5.39 Million
Q1 2024

Apr 26, 2024

SELL
$212.02 - $267.71 $640,724 - $809,019
-3,022 Reduced 11.11%
24,179 $5.21 Million
Q4 2023

Feb 01, 2024

BUY
$222.59 - $267.94 $611,009 - $735,495
2,745 Added 11.22%
27,201 $7.04 Million
Q3 2023

Oct 30, 2023

SELL
$253.3 - $285.89 $153,499 - $173,249
-606 Reduced 2.42%
24,456 $6.29 Million
Q2 2023

Aug 02, 2023

BUY
$275.25 - $318.06 $97,163 - $112,275
353 Added 1.43%
25,062 $7.14 Million
Q1 2023

May 02, 2023

SELL
$256.56 - $292.34 $223,976 - $255,212
-873 Reduced 3.41%
24,709 $6.87 Million
Q4 2022

Jan 09, 2023

BUY
$252.44 - $306.72 $269,353 - $327,270
1,067 Added 4.35%
25,582 $0
Q3 2022

Nov 04, 2022

SELL
$194.69 - $268.46 $54,902 - $75,705
-282 Reduced 1.14%
24,515 $6.55 Million
Q2 2022

Aug 01, 2022

BUY
$187.54 - $223.02 $268,369 - $319,141
1,431 Added 6.12%
24,797 $5.06 Million
Q1 2022

May 12, 2022

BUY
$193.77 - $244.14 $115,874 - $145,995
598 Added 2.63%
23,366 $4.92 Million
Q4 2021

Jan 31, 2022

BUY
$223.92 - $287.77 $5.1 Million - $6.55 Million
22,768 New
22,768 $5.46 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.